Treatment of immunoglobulin A nephropathy: Current perspective and future prospects

doi:10.12998/wjcc.v13.i19.101196

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 19

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (417)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

HTML

298

Figures (1-1)

Sum=367

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=30

Jul 6, 2025 (publication date) through Apr 3, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Clin Cases. Jul 6, 2025; 13(19): 101196
Published online Jul 6, 2025. doi: 10.12998/wjcc.v13.i19.101196

Open in New Tab Full Size Figure Download Figure

Figure 1 Treatment options in immunoglobulin A nephropathy. ACE: Angiotensin converting enzyme; ARB: Angiotensin receptor blockers; APRIL: A proliferation-induced ligand; BAFF: B-cell-activating factor; SGLT2: Sodium-glucose cotransporter-2. ¹Treatment options with proven certain clinical benefits by clinical trials.

Citation: Şener YZ, Şener S. Treatment of immunoglobulin A nephropathy: Current perspective and future prospects. World J Clin Cases 2025; 13(19): 101196
URL: https://www.wjgnet.com/2307-8960/full/v13/i19/101196.htm
DOI: https://dx.doi.org/10.12998/wjcc.v13.i19.101196